Position in DXCM
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$45,124
+$26,912 QoQ
Shares Held
670
+131.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#774
of 966 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Banque Transatlantique SA holds $106,168,720 across 9 Medical Devices names. DXCM ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
183,559 | $57,791,715 | |
| 2 | BSX |
Boston Scientific Corp
|
914,874 | $39,046,822 | |
| 3 | ABT |
Abbott Laboratories
|
31,530 | $2,861,032 | |
| 4 | EW |
Edwards Lifesciences Corp
|
31,340 | $2,835,016 | |
| 5 | PRCT |
PROCEPT BioRobotics Corp
|
118,436 | $2,674,284 | |
| 6 | MDT |
Medtronic plc
|
9,620 | $752,572 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
2,040 | $130,580 | |
| 8 | DXCM |
Dexcom Inc
This page
|
670 | $45,124 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,124 | 670 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $18,212 | 290 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $44,467 | 670 | Shares | Defined | 2026-02-26 | |
| 2025-09-30 | $65,271 | 970 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $130,935 | 1,500 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $102,435 | 1,500 | Shares | Defined | 2025-09-09 | |
| 2024-12-31 | $116,655 | 1,500 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||